title: Idiopathic nonhistaminergic angioedema successfully treated with ecallantide, icatibant, and C1 esterase inhibitor replacement.
authors.affiliation: Allergy/Immunology, Wright-Patterson Medical Center, Wright-Patterson Air Force Base, Ohio. Electronic address: docstahl@yahoo.com.
authors.forename: Mark C
authors.initials: MC
authors.lastname: Stahl
authors.affiliation: Boonshoft School of Medicine, Department of Medicine, Wright State University, Dayton, Ohio.
authors.forename: Caitlin K
authors.initials: CK
authors.lastname: Harris
authors.affiliation: Boonshoft School of Medicine, Department of Medicine, Wright State University, Dayton, Ohio.
authors.forename: Sulaiman
authors.initials: S
authors.lastname: Matto
authors.affiliation: Division of Immunology/Allergy Section, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio.
authors.forename: Jonathan A
authors.initials: JA
authors.lastname: Bernstein
mesh_terms: D000328:Adult; D000799:Angioedema / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D001920:Bradykinin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D050718:Complement C1 Inhibitor Protein / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D010455:Peptides / Q000627:therapeutic use*; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D050718:Complement C1 Inhibitor Protein; D007155:Immunologic Factors; D010455:Peptides; C511194:ecallantide; C065679:icatibant; D001920:Bradykinin